Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Food and Drug Regulations

Version of section G.04.001 from 2019-12-09 to 2024-03-06:


Marginal note:Restriction

  •  (1) Subject to subsections (2) and (3) and to an exemption granted under section 56 of the Act with respect to the administration of the controlled drug specified in the exemption, a practitioner must not administer a controlled drug to any person or animal.

  • Marginal note:Conditions

    (2) A practitioner may administer a controlled drug, other than a designated drug, to a person or to an animal, if

    • (a) that person or animal is under their professional treatment; and

    • (b) the controlled drug is required for the condition for which that person or animal is receiving treatment.

  • Marginal note:Purposes

    (3) A practitioner of medicine, dentistry or veterinary medicine or a nurse practitioner may administer a designated drug to a person or animal who is under their professional treatment if the designated drug is for the treatment of any of the following conditions:

    • (a) in the case of persons,

      • (i) narcolepsy,

      • (ii) hyperkinetic disorders in children,

      • (iii) epilepsy,

      • (iv) parkinsonism, or

      • (v) hypotensive states associated with anesthesia; or

    • (b) in the case of animals, depression of cardiac and respiratory centres.

  • Marginal note:Definitions

    (4) The following definitions apply in this section.

    administer

    administer includes to prescribe, sell or provide a drug. (administrer)

    designated drug

    designated drug means any of the following controlled drugs:

    • (a) amphetamine and its salts;

    • (b) benzphetamine and its salts;

    • (c) methamphetamine and its salts;

    • (d) phenmetrazine and its salts; or

    • (e) phendimetrazine and its salts. (drogue désignée)

  • SOR/99-125, s. 4
  • SOR/2004-238, s. 23
  • SOR/2012-230, s. 12
  • SOR/2019-171, s. 13

Date modified: